- Presentations
- 4
- Markets
- 1
Granix is a brand of Filgrastim marketed by Cephalon, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Filgrastim
- Brand owner
- Cephalon
- Registered in
- United States
- Strengths and forms
- 300 mcg/0.5 mL injection, 300 mcg/1 mL injection, 480 mcg/0.8 mL injection, 480 mcg/1.6 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Granix 300 mcg/0.5 mL injectionSubcutaneous Cold chain | Cephalon | US FDA | Available on request |
| Granix 300 mcg/1 mL injectionSubcutaneous Cold chain | Cephalon | US FDA | Available on request |
| Granix 480 mcg/0.8 mL injectionSubcutaneous Cold chain | Cephalon | US FDA | Available on request |
| Granix 480 mcg/1.6 mL injectionSubcutaneous Cold chain | Cephalon | US FDA | Available on request |
Equivalent brands
Other brands of Filgrastim.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Granix
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.